|
US2799241A
(en)
|
1949-01-21 |
1957-07-16 |
Wisconsin Alumni Res Found |
Means for applying coatings to tablets or the like
|
|
US4160861A
(en)
|
1977-10-03 |
1979-07-10 |
Merck & Co., Inc. |
Method for the separation of antibiotic macrolides
|
|
US4584369A
(en)
|
1981-07-31 |
1986-04-22 |
Sloan-Kettering Institute For Cancer Research |
Anti-leukemic beta-glycosyl C-nucleosides
|
|
JPS5939889A
(ja)
|
1982-08-30 |
1984-03-05 |
Noguchi Kenkyusho |
２，４，６↓−トリ↓−０↓−アセチル↓−３↓−デオキシ↓−ヘキソノ↓−１，５↓−ラクトンの製造方法
|
|
JP2544609B2
(ja)
|
1986-10-07 |
1996-10-16 |
和光純薬工業株式会社 |
Ｔｃｎｑ錯体
|
|
CA1327013C
(en)
|
1988-06-23 |
1994-02-15 |
Peter Rex Brawn |
Cosmetic composition
|
|
DE68920798T2
(de)
|
1988-08-19 |
1995-05-18 |
Warner Lambert Co |
Substituierte Dihydroisochinolinone und verwandte Verbindungen als Verstärker der letalen Effekte von Bestrahlung und bestimmten Chemotherapeutika; ausgewählte Verbindungen, Analoga und Verfahren.
|
|
DE59105613D1
(de)
|
1990-08-24 |
1995-07-06 |
Spirig Ag |
Verfahren zur Herstellung von Pellets.
|
|
JPH04253974A
(ja)
|
1991-02-05 |
1992-09-09 |
Ishihara Sangyo Kaisha Ltd |
スルホニル尿素系化合物、それらの製造方法及びそれらを含有する除草剤
|
|
EP0517969A1
(en)
|
1991-06-10 |
1992-12-16 |
AUSIMONT S.p.A. |
Process for increasing the bleaching efficiency of an inorganic persalt or of hydrogen peroxide
|
|
US5149838A
(en)
|
1991-09-20 |
1992-09-22 |
Merck & Co., Inc. |
Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents
|
|
US5610294A
(en)
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
|
MX9205392A
(es)
|
1991-10-29 |
1993-04-01 |
Du Pont |
Triazolcarbozamidas herbicidas y procedimiento para su obtencion.
|
|
GB9208161D0
(en)
|
1992-04-14 |
1992-05-27 |
Pfizer Ltd |
Indoles
|
|
US5334225A
(en)
|
1992-07-15 |
1994-08-02 |
Kao Corporation |
Keratinous fiber dye composition containing a 2-substituted amino-5-alkylphenol derivative coupler
|
|
CA2102591C
(en)
|
1992-11-12 |
2000-12-26 |
Kenji Tsujihara |
Hypoglycemic agent
|
|
US5731292A
(en)
|
1992-11-12 |
1998-03-24 |
Tanabe Seiyaku Co., Ltd. |
Dihydrochalcone derivatives which are hypoglycemic agents
|
|
DE4243279A1
(de)
|
1992-12-21 |
1994-06-23 |
Bayer Ag |
Substituierte Triole
|
|
US6297363B1
(en)
|
1993-02-12 |
2001-10-02 |
Nomura Co., Ltd. |
Glycoside indoles
|
|
JPH06256354A
(ja)
|
1993-03-01 |
1994-09-13 |
Nippon Nohyaku Co Ltd |
新規テトラゾール化合物及びその製法
|
|
JP3187611B2
(ja)
|
1993-05-17 |
2001-07-11 |
キヤノン株式会社 |
液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置
|
|
JPH07242526A
(ja)
|
1994-03-03 |
1995-09-19 |
Sogo Yatsukou Kk |
化粧料
|
|
US5830873A
(en)
|
1994-05-11 |
1998-11-03 |
Tanabe Seiyaku Co., Ltd. |
Propiophenone derivative and a process for preparing the same
|
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
DE69634045T2
(de)
|
1995-10-31 |
2005-05-19 |
Eli Lilly And Co., Indianapolis |
Antithrombotische diamine
|
|
JP3059088B2
(ja)
|
1995-11-07 |
2000-07-04 |
田辺製薬株式会社 |
プロピオフェノン誘導体およびその製法
|
|
US5723495A
(en)
|
1995-11-16 |
1998-03-03 |
The University Of North Carolina At Chapel Hill |
Benzamidoxime prodrugs as antipneumocystic agents
|
|
JPH09263549A
(ja)
|
1996-01-25 |
1997-10-07 |
Fujisawa Pharmaceut Co Ltd |
ベンゼン誘導体の製造法
|
|
IL121525A0
(en)
|
1996-08-26 |
1998-02-08 |
Tanabe Seiyaku Co |
Process for preparing optically active benzothiazepine compound and intermediate therefor
|
|
ES2176600T3
(es)
|
1996-12-26 |
2002-12-01 |
Tanabe Seiyaku Co |
Derivado de la propiofenona y procedimientos para su preparacion.
|
|
US6153632A
(en)
|
1997-02-24 |
2000-11-28 |
Rieveley; Robert B. |
Method and composition for the treatment of diabetes
|
|
AU6422298A
(en)
|
1997-03-25 |
1998-10-20 |
Takeda Chemical Industries Ltd. |
Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
|
|
AP1224A
(en)
|
1998-03-19 |
2003-11-14 |
Bristol Myers Squibb Co |
Biphasic controlled release delivery system for high solubility pharmaceuticals and method.
|
|
FR2780403B3
(fr)
|
1998-06-24 |
2000-07-21 |
Sanofi Sa |
Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
|
|
JP2000034239A
(ja)
|
1998-07-16 |
2000-02-02 |
Asahi Glass Co Ltd |
トリフルオロメチル化芳香族化合物の製造方法
|
|
JP3857429B2
(ja)
|
1998-07-17 |
2006-12-13 |
ポーラ化成工業株式会社 |
含硫黄抗真菌剤
|
|
US6069238A
(en)
|
1998-09-30 |
2000-05-30 |
Eli Lilly And Company |
Spirocyclic C-glycosides
|
|
CN1325385A
(zh)
|
1998-11-09 |
2001-12-05 |
詹姆斯·布莱克基金有限公司 |
胃泌素和缩胆囊素受体配体
|
|
EA007610B1
(ru)
|
1998-11-12 |
2006-12-29 |
Смитклайн Бичам Плс |
Таблетка с энтеропокрытием, обеспечивающая отсроченное высвобождение
|
|
US20020032164A1
(en)
|
1998-12-30 |
2002-03-14 |
Dale Roderic M. K. |
Antimicrobial compounds and methods for their use
|
|
GB9912961D0
(en)
|
1999-06-03 |
1999-08-04 |
Pfizer Ltd |
Metalloprotease inhibitors
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
EP1229918B1
(en)
|
1999-11-03 |
2008-03-26 |
Bristol-Myers Squibb Company |
Pharmaceutical composition comprising a combination of metformin and glibenclamide
|
|
JP3450810B2
(ja)
|
2000-01-31 |
2003-09-29 |
キヤノン株式会社 |
脂肪族ポリエステル、脂肪族ポリエステルの製造方法およびセルロースの再資源化方法
|
|
US6627611B2
(en)
|
2000-02-02 |
2003-09-30 |
Kotobuki Pharmaceutical Co Ltd |
C-glycosides and preparation of thereof as antidiabetic agents
|
|
JP4456768B2
(ja)
|
2000-02-02 |
2010-04-28 |
壽製薬株式会社 |
Ｃ−配糖体を含有する薬剤
|
|
WO2001064669A1
(en)
|
2000-03-03 |
2001-09-07 |
Pfizer Products Inc. |
Pyrazole ether derivatives as anti-inflammatory/analgesic agents
|
|
CZ20023023A3
(cs)
|
2000-03-17 |
2003-04-16 |
Kissei Pharmaceutical Co., Ltd. |
Glukopyranosyloxybenzylbenzenové deriváty, léčivé směsi obsahující tyto látky a meziprodukty pro přípravu derivátů
|
|
US6555519B2
(en)
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
|
US6683056B2
(en)
|
2000-03-30 |
2004-01-27 |
Bristol-Myers Squibb Company |
O-aryl glucoside SGLT2 inhibitors and method
|
|
GB0011098D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
|
|
EP1172362A1
(de)
|
2000-07-11 |
2002-01-16 |
Basf Aktiengesellschaft |
Azadioxacycloalkene und ihre Verwendung zur Bekämpfung von Schadpilzen und tierischen Schädlingen
|
|
KR100426030B1
(ko)
|
2000-07-22 |
2004-04-03 |
(주) 한켐 |
락톤계 당화합물에서의 키랄성 전환방법
|
|
WO2002026706A2
(en)
|
2000-09-29 |
2002-04-04 |
Bayer Pharmaceuticals Corporation |
17-beta-hydroxysteroid dehydrogenase-ii inhibitors
|
|
ES2337127T3
(es)
|
2000-11-02 |
2010-04-21 |
Ajinomoto Co., Inc. |
Nuevos derivados de pirazol y remedios contra la diabetes que los contienen.
|
|
JP2002167430A
(ja)
|
2000-12-01 |
2002-06-11 |
Canon Inc |
脂肪族ポリエステル、脂肪族ポリエステルの製造方法およびデンプンの資源化方法
|
|
US6476352B2
(en)
|
2000-12-18 |
2002-11-05 |
General Electric Company |
Laser beam stop sensor and method for automatically detecting the presence of laser beam stop material using a laser beam stop sensor
|
|
MXPA03005923A
(es)
|
2000-12-28 |
2004-01-26 |
Kissei Pharmaceuticals Co Ltd |
Derivados de glupopiranosiloxipirazol y su uso en medicinas.
|
|
WO2002068439A1
(fr)
|
2001-02-26 |
2002-09-06 |
Kissei Pharmaceutical Co., Ltd. |
Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
|
|
US7294618B2
(en)
|
2001-02-27 |
2007-11-13 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxypyrazole derivatives and medicinal use thereof
|
|
US7018610B2
(en)
|
2001-03-02 |
2006-03-28 |
University Of Western Ontario |
Polymer precursors of radiolabeled compounds, and methods of making and using the same
|
|
US6936590B2
(en)
|
2001-03-13 |
2005-08-30 |
Bristol Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
ATE318272T1
(de)
|
2001-04-11 |
2006-03-15 |
Bristol Myers Squibb Co |
Aminosäurekomplexe von c-arylglycosiden zur behandlung von diabetes und verfahren
|
|
JP4292570B2
(ja)
|
2001-04-27 |
2009-07-08 |
味の素株式会社 |
Ｎ−置換ピラゾール−ｏ−グリコシド誘導体及びそれらを含有する糖尿病治療薬
|
|
GB0112122D0
(en)
|
2001-05-18 |
2001-07-11 |
Lilly Co Eli |
Heteroaryloxy 3-substituted propanamines
|
|
US7105556B2
(en)
|
2001-05-30 |
2006-09-12 |
Bristol-Myers Squibb Company |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
|
|
WO2003000712A1
(en)
|
2001-06-20 |
2003-01-03 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
|
|
JP4115105B2
(ja)
|
2001-07-02 |
2008-07-09 |
協和醗酵工業株式会社 |
ピラゾール誘導体
|
|
WO2003011880A1
(fr)
|
2001-07-31 |
2003-02-13 |
Kissei Pharmaceutical Co., Ltd. |
Derive de glucopyranosyloxybenzylbenzene, composition medicinale contenant ce derive, usage medicinal de cette composition et produit intermediaire pour produire cette composition
|
|
US20030191121A1
(en)
|
2001-08-09 |
2003-10-09 |
Miller Ross A. |
Piperazine carboxamide intermediates of HIV protease inhibitors and processes for their preparation
|
|
US20030087843A1
(en)
|
2001-09-05 |
2003-05-08 |
Washburn William N. |
O-pyrazole glucoside SGLT2 inhibitors and method of use
|
|
EP1438424B1
(en)
|
2001-10-24 |
2006-01-18 |
Michael Burton |
Enzyme substrates for detecting beta-d-ribofuranosidase activity
|
|
DK1443915T3
(da)
|
2001-11-16 |
2006-10-23 |
Cutanix Corp |
Farmaceutiske og kosmetiske præparater indeholdende aromatiske aldehyder, der bærer en oxygruppe
|
|
JP2003238417A
(ja)
|
2002-02-18 |
2003-08-27 |
Nippon Shoyaku Kenkyusho:Kk |
フロレチン配糖体の安定化組成物、該安定化組成物を含有する糖尿病予防・治療剤、および保健食品
|
|
US6617313B1
(en)
|
2002-03-13 |
2003-09-09 |
Council Of Scientific And Industrial Research |
Glucopyranoside and process of isolation thereof from pterocarpus marsupium pharmaceutical composition containing the same and use thereof
|
|
US6562791B1
(en)
|
2002-03-29 |
2003-05-13 |
Council Of Scientific And Industrial Research |
Glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
|
|
JP2003313168A
(ja)
|
2002-04-18 |
2003-11-06 |
Kirin Brewery Co Ltd |
Ｂｃｌ−２阻害活性を有する化合物およびその化合物のスクリーニング方法
|
|
MXPA04010190A
(es)
|
2002-04-18 |
2005-02-03 |
Astrazeneca Ab |
Compuestos heterociclicos.
|
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
TWI254635B
(en)
|
2002-08-05 |
2006-05-11 |
Yamanouchi Pharma Co Ltd |
Azulene derivative and salt thereof
|
|
UA77300C2
(en)
|
2002-08-09 |
2006-11-15 |
Taisho Pharmaceutical Co Ltd |
5-thio-?-d-glucopyranoside derivatives and pharmaceutical composition for treating diabetes
|
|
AU2003262262A1
(en)
|
2002-08-27 |
2004-03-19 |
Kissei Pharmaceutical Co., Ltd. |
Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
|
|
CA2501239A1
(en)
|
2002-10-07 |
2004-04-22 |
Encore Pharmaceuticals, Inc. |
R-nsaid esters and their use
|
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
JP2006516257A
(ja)
|
2003-01-03 |
2006-06-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｃ−アリールグルコシドｓｇｌｔ２阻害剤の製造法
|
|
GB0301259D0
(en)
|
2003-01-20 |
2003-02-19 |
Novartis Ag |
Organic compounds
|
|
EP1597266A4
(en)
|
2003-02-27 |
2008-02-20 |
Bristol Myers Squibb Co |
NON-CRYOGENIC PROCESS FOR THE PRODUCTION OF GLYCOSIDES
|
|
PL1609785T3
(pl)
|
2003-03-14 |
2016-07-29 |
Astellas Pharma Inc |
Pochodne c-glikozydowe i ich sole
|
|
JP2004300102A
(ja)
|
2003-03-31 |
2004-10-28 |
Kissei Pharmaceut Co Ltd |
縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
|
|
AU2003902263A0
(en)
|
2003-05-12 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Monosaccharide compounds
|
|
US7576064B2
(en)
|
2003-06-20 |
2009-08-18 |
Kissei Pharmaceutical Co., Ltd. |
Pyrazole derivative, drug composition containing the same and production intermediate therefor
|
|
HRP20110180T1
(hr)
|
2003-07-23 |
2011-04-30 |
Synta Pharmaceuticals Corporation |
Spojevi za upotrebu kod upala i upotrebe vezane uz imunitet
|
|
UA86042C2
(en)
|
2003-08-01 |
2009-03-25 |
Янссен Фармацевтика Н.В. |
Substituted indazole-o-glucosides
|
|
SG130189A1
(en)
|
2003-08-01 |
2007-03-20 |
Janssen Pharmaceutica Nv |
Substituted indole-o-glucosides
|
|
EA011515B1
(ru)
|
2003-08-01 |
2009-04-28 |
Янссен Фармацевтика Н.В. |
Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
|
|
EP1679965A4
(en)
|
2003-08-01 |
2009-05-27 |
Janssen Pharmaceutica Nv |
SUBSTITUTED ANELLIERED HETEROCYCLIC C-GLYCOSIDES
|
|
WO2005012326A1
(en)
|
2003-08-01 |
2005-02-10 |
Tanabe Seiyaku Co., Ltd. |
Novel compounds having inhibitory activity against sodium-dependant transporter
|
|
RS20060320A
(sr)
|
2003-08-01 |
2008-08-07 |
Janssen Pharmaceutica N.V., |
Supstituisani indazol-o-glukozidi
|
|
WO2005058845A2
(en)
|
2003-12-19 |
2005-06-30 |
Novo Nordisk A/S |
Novel glucagon antagonists/inverse agonists
|
|
US7157584B2
(en)
|
2004-02-25 |
2007-01-02 |
Takeda Pharmaceutical Company Limited |
Benzimidazole derivative and use thereof
|
|
CA2557801C
(en)
|
2004-03-16 |
2013-06-25 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
|
|
US7393836B2
(en)
|
2004-07-06 |
2008-07-01 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
WO2006010557A1
(de)
|
2004-07-27 |
2006-02-02 |
Boehringer Ingelheim International Gmbh |
D-glucopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
WO2006018150A1
(de)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
|
WO2006082523A2
(en)
|
2005-01-25 |
2006-08-10 |
Aurobindo Pharma Limited |
Pharmaceutical sustained release composition of metformin
|
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
|
ATE445608T1
(de)
|
2005-02-23 |
2009-10-15 |
Boehringer Ingelheim Int |
Glucopyranosylsubstituierte ((hetero)arylethynyl- benzyl)-benzenderivative und deren verwendung als inhibitoren des natriumabhängigen glucose- cotransporters typ 2 (sglt2)
|
|
EP1874787B1
(en)
|
2005-04-15 |
2009-12-30 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors
|
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
|
EP1910390B1
(en)
|
2005-07-27 |
2010-05-19 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted ((hetero)cycloalyklethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors
|
|
DE602006017566D1
(de)
|
2005-08-30 |
2010-11-25 |
Boehringer Ingelheim Pharma |
Glucopyranosyl-substituierte benzyl-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
|
|
AR056195A1
(es)
|
2005-09-15 |
2007-09-26 |
Boehringer Ingelheim Int |
Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
|
|
AU2007208239B2
(en)
|
2006-01-25 |
2013-04-18 |
Synta Pharmaceuticals Corp. |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
TWI418556B
(zh)
|
2006-07-27 |
2013-12-11 |
Mitsubishi Tanabe Pharma Corp |
吲哚衍生物
|
|
EP2054426A1
(en)
|
2006-08-15 |
2009-05-06 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
|
|
JP5372759B2
(ja)
|
2006-09-21 |
2013-12-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル−置換ジフルオロベンジル−ベンゼン誘導体、該化合物を含有する医薬品及びその使用と調製方法
|
|
US7879806B2
(en)
|
2006-11-06 |
2011-02-01 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzonitrile derivates, medicaments containing such compounds, their use and process for their manufacture
|
|
EA018495B1
(ru)
|
2006-11-09 |
2013-08-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Комбинированное лечение ингибиторами sglt-2 (натрийзависимый сопереносчик глюкозы 2) и содержащими их фармацевтическими композициями
|
|
WO2008070609A1
(en)
|
2006-12-04 |
2008-06-12 |
Janssen Pharmaceutica N.V. |
Thienyl-containing glycopyranosyl derivatives as antidiabetics
|
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
|
EP1956023A1
(en)
|
2007-02-06 |
2008-08-13 |
Lonza Ag |
Method for lithium exchange reactions
|
|
TW200904405A
(en)
*
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
|
CL2008002425A1
(es)
|
2007-08-16 |
2009-09-11 |
Boehringer Ingelheim Int |
Composición farmacéutica que comprende un inhibidor de sglt2 y 1-(4-metil-quinazolin-2-il)metil-3metil-7-(-2-butin-1-il)-8-(3-(r)-amino-piperidin-1il)-xantina, un inhibidor de dpp iv y su uso para el tratamiento de la obesidad y de la diabetes tipo 1 y 2 y complicaciones de esta.
|
|
US7838499B2
(en)
|
2007-08-23 |
2010-11-23 |
Theracos, Inc. |
Benzylbenzene derivatives and methods of use
|
|
NZ600110A
(en)
|
2007-09-10 |
2013-03-28 |
Janssen Pharmaceutica Nv |
Process for the preparation of compounds useful as inhibitors of sglt
|
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
|
PE20140960A1
(es)
|
2008-04-03 |
2014-08-15 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
|
US20090304789A1
(en)
*
|
2008-06-09 |
2009-12-10 |
Thomas Najarian |
Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
|
|
US9056850B2
(en)
|
2008-10-17 |
2015-06-16 |
Janssen Pharmaceutica N.V. |
Process for the preparation of compounds useful as inhibitors of SGLT
|
|
WO2010045656A2
(en)
|
2008-10-17 |
2010-04-22 |
Nectid, Inc. |
Novel sglt2 inhibitor dosage forms
|
|
HUE050287T2
(hu)
|
2009-02-13 |
2020-11-30 |
Boehringer Ingelheim Int |
SGLT2-inhibitort, DPP-IV-inhibitort és adott esetben egy további antidiabetikus hatóanyagot tartalmazó gyógyászati készítmény és alkalmazásai
|
|
WO2011008490A2
(en)
*
|
2009-06-29 |
2011-01-20 |
Metabolous Pharmaceuticals, Inc. |
Combination therapies for the treatment of obesity
|
|
US20110009347A1
(en)
|
2009-07-08 |
2011-01-13 |
Yin Liang |
Combination therapy for the treatment of diabetes
|
|
PH12012500698A1
(en)
|
2009-10-14 |
2016-05-27 |
Janssen Pharmaceutica Nv |
Process for the preparation of compounds useful as inhibitors of sglt2
|
|
ES2596291T3
(es)
|
2010-05-11 |
2017-01-05 |
Janssen Pharmaceutica, N.V. |
Formulaciones farmacéuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienilmetilbenceno como inhibidores de sglt
|
|
CN106890147A
(zh)
*
|
2010-05-11 |
2017-06-27 |
田边三菱制药株式会社 |
含1‑(β‑D‑吡喃葡糖基)‑3‑(苯基噻吩基甲基)苯化合物的片剂
|